Endothelial-coagulative activation during chronic obstructive pulmonary disease exacerbations

Haematologica

Volumn 93, Issue 8, 2008, Pages 1275-1276

  Polosa, Riccardo ^a   Cacciola, Rossella R ^a   Prosperini, Gaetano ^b   Spicuzza, Lucia ^a   Morjaria, Jaymin B ^c   Di Maria, Giuseppe U ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CANNIZZARO HOSPITAL   (Italy)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Clotting; D dimer; F1+2; IL 6; Inflammation; vWF

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; D DIMER; INTERLEUKIN 6; OXYGEN; PROTHROMBIN; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTHELIAL COAGULATIVE SYSTEM; HEMATOPOIETIC SYSTEM; HUMAN; INFLAMMATION; LETTER; THROMBOCYTE AGGREGATION;

ANTIGENS; BIOLOGICAL MARKERS; BLOOD COAGULATION; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM;

EID: 48749090209     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12473     Document Type: Letter

References (12)

1. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003;48:1204-13.
2. Ambrosetti M, Ageno W, Spanevello A, Salerno M, Pedretti RF. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Thromb Res 2003;112:203-7.
3. Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia. Thorax 1991;46:504-7.
4. Alessandri C, Basili S, Violi F, Ferroni P, Gazzaniga PP, Cordova C. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group. Thromb Haemost 1994; 72:343-6.
5. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000;84:210-5.
6. Lowe GD. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006;133:232-50.
7. Querol-Ribelles JM, Tenias JM, Grau E, Querol-Borras JM, Climent JL, Gomez E, et al. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest 2004;126:1087-92.
8. Shilon Y, Shitrit AB, Rudensky B, Yinnon AM, Margalit M, Sulkes J, et al. A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia. Blood Coagul Fibrinolysis 2003;14:745-8.
9. Horan JT, Francis CW, Falsey AR, Kolassa J, Smith BH, Hall WJ. Prothrombotic changes in hemostatic parameters and Creactive protein in the elderly with winter acute respiratory tract infections. Thromb Haemost 2001;85:245-9.
10. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003;124:459-67.
11. Neuhaus A, Bentz RR, Weg JG. Pulmonary embolism in respiratory failure. Chest 1978;73:460-5.
12. Prescott SM, Richards KL, Tikoff G, Armstrong JD Jr, Shigeoka JW. Venous thromboembolism in decompensated chronic obstructive pulmonary disease. A prospective study. Am Rev Respir Dis 1981;123:32-6.